IN WHAT scientists are saying could be "the biggest breakthrough in neurodegenerative diseases for 50 years" a University College London research team has safely lowered levels of toxic proteins in the brain with an experimental drug injected into spinal fluid.
A debilitating disease with an unenviable vegetative state at the end, Huntington's is genetically transmitted and devastates families as brain cells die in what has been an unstoppable way.
The new treatment is designed to silence the gene that corrupts the protein converting it to a killer of brain cells.
The therapy was developed by Ionis Pharmaceuticals, which said the drug had "substantially exceeded" expectations, and the licence has now been sold to Roche, reports BBC News.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Dec 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Dec 17